As of April, 25 Analysts See $4.93 EPS for Anthem, Inc. (ANTM)

Lloyd Doyle
April 25, 2018

After $1.29 actual EPS reported by Anthem, Inc. for the previous quarter, Wall Street now forecasts 282.17% EPS growth.

In related news, Director Ramiro G. Peru sold 2,681 shares of the firm's stock in a transaction dated Tuesday, May 30th. About 153,888 shares traded.

Anthem, Inc. (ANTM) added 0.5% to reach $227.2 in the previous trading session. The stock outperformed the S&P500 by 23.75%.

Vident Investment Advisory Llc increased its stake in Carter Inc (CRI) by 83.12% based on its latest 2017Q4 regulatory filing with the SEC. 68,512 shares were sold by Apg Asset Management Nv as the company's stock declined 2.73% with the market. About 62,136 shares traded.

They now have a $275.0000 TP on Anthem Inc (NYSE:ANTM).

Rival Aetna is expected to be bought for $69 billion by pharmacy chain CVS Health and Cigna has proposed acquiring Express Scripts, the largest USA independent pharmacy benefit manager, for $54 billion.


Investors sentiment is 1.09 in 2017 Q4. Its the same as in 2017Q3. Insiders own 0.31% of the company's stock. (NYSE:CRI). Df Dent And Company holds 0.01% in Carter's, Inc.

On 3/13/2018 Thomas C Zielinski, EVP, sold 20,455 with an average share price of $229.23 per share and the total transaction amounting to $4,688,899.65.

AGF Management Limited is a publicly owned asset management holding company. Clearbridge Ltd Limited Liability Company invested in 0% or 120 shares. Its strong capital position backs effective capital deployment via share buyback programs and regular dividend payments. Geode Cap Mgmt Ltd Liability Corp has invested 0.02% in Carter's, Inc.

Shares of Indianapolis-based Anthem advanced $2 to $227 before markets opened. Ten analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Therefore 67% are positive. (NYSE:ANTM) has 86% bullish analysts. (NYSE:ANTM) has "Equal-Weight" rating given on Thursday, February 1 by Morgan Stanley. The company rating was maintained by Cowen & Co on Wednesday, January 31. On Monday, November 6 the firm has "Buy" rating by Cantor Fitzgerald given. On Thursday, February 1 Credit Suisse maintained Anthem, Inc. Anthem presently has a consensus rating of "Buy" and a consensus target price of $236.13. It also reduced its holding in Quest Diagnostics Inc (NYSE:DGX) by 12,400 shares in the quarter, leaving it with 99,700 shares, and cut its stake in Amdocs Ltd (NASDAQ:DOX). Therefore 14% are positive. Anthem had 20 analyst reports since October 26, 2017 according to SRatingsIntel. Piper Jaffray initiated the stock with "Neutral" rating in Wednesday, January 4 report. The stock has "Outperform" rating by Wells Fargo on Thursday, February 1. RBC Capital Markets maintained Anthem, Inc. In Thursday, January 25 report Bernstein maintained the stock with "Buy" rating.

Analysts await Anthem, Inc. On Wednesday, January 3 the stock has "Hold" rating by Goldman Sachs. In Friday, November 17 report Bank of America maintained it with "Buy" rating and $254 target. The firm has "Buy" rating by RBC Capital Markets given on Tuesday, May 30. Jefferies Group LLC reiterated a "hold" rating and issued a $183.00 target price (up previously from $177.00) on shares of Anthem in a report on Sunday, April 23rd. Cantor Fitzgerald upgraded the shares of ANTM in report on Friday, April 28 to "Overweight" rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER